Skip to main content
United States District Court
Eastern District of Pennsylvania
Honorable Mitchell S. Goldberg, Chief Judge | George V. Wylesol, Clerk of Court
Search form
Search this site
Court Info
FAQs
Court Locations
Court Proceeding Schedule
Departments
Court Holidays
Fees
Local Rules, Standing and Administrative Orders
Vacancy Announcements
Clerk's Office Procedures
Notices
Contact Information
Emergency Contact Information
Judicial Conduct & Disability
Office of Workplace Relations
Employment Dispute Resolution (EDR) Plan
Anti-Discrimination and Harassment Contact Information
Court History
Judges of the Court 1789 to Present
Judges' Info
Our Judges
Documents
MDL
Forms
Three Judge Court Cases
Opinions
Federal Rules
Notices
Programs & Services
NextGen CM/ECF
PACER
Volunteer Attorney Panels
Electronic Courtrooms
Accessibility Information
STRIDES Program
Reentry Court
Relapse Prevention Court
Ordering Transcripts
Arbitration Trials
Mediation
Jury Info
For Attorneys
Pro Se - Self Representation
Overview of the Federal Courts
Filing Your Complaint
Pro Se Forms
Electronic Document Submission (EDS)
Legal Terms and Rules
Legal Resources
Case Info
CM/ECF Case Info
Criminal Justice Act
You are here
Home
Documents
MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation
Date
02/15/2024
Case Management Order No. 1 - Notice of Initial Organizational Conference and Related Preliminary Matters
04/23/2024
Case Management Order No. 3 - Appointment of Plaintiffs’ Committee
04/23/2024
Case Management Order No. 4 - Preservation Order
05/08/2024
Case Management Order No. 6 - Appointment of Plaintiff Leadership
06/10/2024
Case Management Order No. 8 - New Procedures for Pro Hac Vice Admission
06/25/2024
Case Management Order No. 9 - Privilege Logging
07/14/2024
Case Management Order No. 10 - Rule 502d Order
07/14/2024
Case Management Order No. 11 - Qualified Protective Order & Sealing Process Order
07/14/2024
Case Management Order No. 12 - Plaintiff Fact Sheets
07/14/2024
Case Management Order No. 13 - Dismissal of Certain Novo Nordisk Defendants
07/14/2024
Case Management Order No. 14 - Direct Filing Order
07/31/2024
Case Management Order No. 15 - ESI Protocol
07/31/2024
Case Management Order No. 16 - Special Master Appointment and Protocol
08/08/2024
Case Management Order No. 17 - Time and Expense Protocol and Common Benefit Funds
08/23/2024
Case Management Order No. 18 - Cross Cutting Issues 1 and 2
11/05/2024
Case Management Order No. 21 - Amended Scheduling Order for Cross Cutting Issue No. 1
11/26/2024
Scheduling Order – 2025 Monthly Conferences
12/03/2024
Case Management Order No. 22 - Scheduling Order for Motions to Dismiss the Master Complaint
03/21/2025
Case Management Order No. 23 - Amended Scheduling Order for Cross Cutting Issue Nos. 2 and 3
03/21/2025
Case Management Order No. 24 - Deposition Protocol for Non-Experts
03/21/2025
Case Management Order No. 25 - Coordination Order
04/16/2025
Case Management Order No. 26 - Plaintiffs’ Production of ESI